Typically, we'll want to notice a trend of growing return on capital employed (ROCE) and alongside that, an expanding base of capital employed. Ultimately, this demonstrates that it's a business that ...

When we last looked at Lantheus in May, its stock was trading just under $80 a share. As a reminder, Lantheus Holdings, Inc.

Lantheus (NASDAQ:LNTH – Get Free Report) had its price objective lowered by B. Riley from $127.00 to $122.00 in a research report issued on Friday,Benzinga reports. The firm currently has a “buy” ...

B. Riley lowered the firm’s price target on Lantheus (LNTH) to $122 from $127 and keeps a Buy rating on the shares. Competitor Telix’s (TLX) ...

In a regulatory filing, Lantheus ( LNTH) Holdings CFO Robert Marshall Jr. disclosed the sale of 10,000 common shares of the company on March 17 at a price of $100.52 per share. Discover stocks' market ...

Learn more about whether Globus Medical, Inc. or Lantheus Holdings, Inc. is a better investment based on AAII's A+ Investor ...

In this article, we are going to take a look at where Lantheus Holdings, Inc. (NASDAQ:LNTH) stands against other best ...

Raymond James Financial Inc. acquired a new position in Lantheus Holdings, Inc. (NASDAQ:LNTH – Free Report) during the fourth ...

Detailed price information for Lantheus Holdings (LNTH-Q) from The Globe and Mail including charting and trades.

Despite challenges, LNTH has potential for further growth, with promising assets in Alzheimer's and oncology, aiming for a double-digit billion market cap by decade's end. As we can see above ...

LNTH), CRISPR Therapeutics AG (Nasdaq: CRSP) and Blueprint Medicines Corp.(Nasdaq: BPMC). Don't miss out on Boston-area life science news. Subscribe to the Morning Edition or Afternoon Edition for ...